[1]Weber MS, Menge T, LehmannHorn K, et al. Current treatment strategies for multiple sclerosis-efficacy versus neurological adverse effects[J]. Curr Pharm Des, 2012, 18(2):209-219.
[2]Steinman L. Multiple sclerosis: a two-stage disease[J]. Nat Immunol, 2001, 2(9):762-764.
[3]Su M, Song Y, He Z, et al. Administration of embryonic stem cell-derived thymic epithelial progenitors expressing MOG induces antigen-specific tolerance and ameliorates experimental autoimmune encephalomyelitis[J]. J Autoimmun, 2015, 58(1):36-47.
[4]Dou M, Zhou X, Li L, et al. Illumination of molecular pathways in multiple sclerosis lesions and the immune mechanism of matrine treatment in EAE, a mouse model of MS[J]. Front Immunol, 2021, 12(12):640778.
[5]Ye TZ, Gordon CT, Lai YH, et al. Ermap, a gene coding for a novel erythroid specific adhesion/receptor membrane protein[J]. Gene, 2000, 24 (1-2):337-345.
[6]Rhodes DA, Reith W, Trowsdale J. Regulation of Immunity by Butyrophilins[J]. Annu Rev Immunol, 2016, 34(6):151-172.
[7]Su M, Lin YJ, Cui C, et al. ERMAP is a B7 family-related molecule that negatively regulates T cell and macrophage responses[J]. Cell Mol Immunol, 2021, 18(8):1920-1933.
[8]Feng J, Li XSh, Hou ZhJ. Advances in study of Th17 cell differentiation and regulation[J]. Chinese Journal of Immunology, 2021, 37(13):1648-1655. (in Chinese)
冯婧,李新胜,侯振江. Th17细胞分化与调控的研究进展[J]. 中国免疫学杂志,2021,37(13):1648-1655.
[9]Ge XL, Cao Y, Wang TT. The features of Th17 in the intestine and its function in inflammatory bowel disease[J]. Chinese Journal of Immunology, 2014, 30(12):1113-1117. (in Chinese)
葛晓龙,曹裕,王婷婷. 肠道内Th17细胞的特征及其在炎症性肠病中的作用[J]. 中国免疫学杂志,2014,30 (12): 1113-1117.
[10]McGinley AM, Edwards SC, Raverdeau M, et al. Th17 cells, gamma delta T cells and their interplay in EAE and multiple sclerosis[J]. J Autoimmunity, 2018, 87(18):97-108.
[11]Moser T, Akgun K, Proschmann U, et al. The role of TH17 cells in multiple sclerosis: therapeutic implications[J]. Autoimmun Rev, 2020, 19(10):102647.
[12]Campisi L, Barbet G, Ding Y, et al. Apoptosis in response to microbial infection induces autoreactive TH17 cells[J]. Nat Immunol, 2016, 17(9):1084-1092.
[13]Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells[J]. Nat Immunol, 2007, 8(9):950-957.
[14]Bettelli E, Carrier Y, Gao W, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells[J]. Nature, 2006, 441(7090):235-238.
[15]Liao WP, Hu R, Huang Y, et al. Therapeutic effect of allogeneic bone marrow mesenchymal stem cell transplantation on experimental autoimmune encephalomyelitis in mice[J]. Acta Anatomica Sinica,2017,48(3) : 266-272. (in Chinese)
廖文萍,胡蓉,黄悦, 等. 骨髓间充质干细胞异体移植对小鼠实验性自身免疫性脑脊髓炎的治疗作用[J]. 解剖学报,2017,48(3): 266-272.
[16]Nguyen T, Liu XK, Zhang Y, et al. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation[J]. J Immunol, 2006, 176(12):7354-7360.
[17]Smith IA, Knezevic BR, Ammann JU, et al. BTN1A1, the mammary gland butyrophilin, and BTN2A2 are both inhibitors of T cell activation[J]. J Immunol, 2010, 184(7):3514-3525.
[18]Aggarwal S, Ghilardi N, Xie MH, et al. Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17[J]. J Biol Chem, 2003, 278(3):1910-1914.
[19]Lee GR. The balance of Th17 versus Treg cells in autoimmunity[J]. Int J Mol Sci, 2018, 19(3):730.
[20]Longhi MS, Mieli-Vergani G, Vergani D. Regulatory T cells in autoimmune hepatitis: an updated overview[J]. J Autoimmun, 2021, 119(3):102619.
[21]Goschl L, Scheinecker C, Bonelli M. Treg cells in autoimmunity: from identification to Treg-based therapies[J]. Semin Immunopathol, 2019, 41(3):301-314.
[22]Owen KL, Brockwell NK, Parker BS. JAK-STAT signaling: a double-edged sword of immune regulation and cancer progression[J]. Cancers (Basel), 2019, 11(12):2002.
[23]Peters A, Fowler KD, Chalmin F, et al. IL-27 induces Th17 differentiation in the absence of STAT1 signaling[J]. J Immunol, 2015, 195(9):4144-4153.
|